Beyond Next Ventures and MBC BioLabs invite you to explore the latest in Japanese life science innovation on January 10th, when seven startups specially selected for the Tokyo prefectural government’s Blockbuster TOKYO initiative will pitch at MBC BioLabs San Francisco. The pitches will be followed by a networking reception, and the event will provide a unique opportunity to learn about and access Japan’s burgeoning bioventure ecosystem.
About Beyond Next Ventures
Beyond Next Ventures is a seed/early-stage Tokyo-based venture capital firm focusing on medtech and life science. Their first fund was established in 2015, with US $55 million in committed as the lead investor in 23 companies. Their second fund of US $100 million was established in October 2018. They also serve as a certified venture capital firm for Japanese government-associated organizations such as the New Energy and Industrial Technology Development Organization and the Program for Start-ups from Advanced Research & Technology. They also operate BRAVE, Japan’s largest university startup accelerator, and have been exclusively tasked by the Tokyo Prefectural Government with operating the Blockbuster TOKYO accelerator for drug discovery startups. Finally, their Innovation Leaders Program gives employees of large corporations the opportunity to extern/embed at startups, and in February 2018 they established a wet lab laboratory space in Tokyo to support and advance the local biotech ecosystem.